The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion : a randomized crossover trial in uraemic patients. / Øzbay, Aygen; Møller, N; Juhl, C; Bjerre, M; Carstens, J; Rungby, J; Jørgensen, K A.

I: Diabetic Medicine, Bind 29, Nr. 12, 2012, s. e440-4.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{52c5e39eccc14f9395476b73993d164b,
title = "The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients",
abstract = "The calcineurin inhibitors cyclosporine and tacrolimus are implicated in post-transplant complications such as new-onset diabetes after transplantation. The relative contribution of each calcineurin inhibitor to new-onset diabetes after transplantation remains unclear. We sought to compare the impact of cyclosporine and tacrolimus on glucose metabolism in humans.",
author = "Aygen {\O}zbay and N M{\o}ller and C Juhl and M Bjerre and J Carstens and J Rungby and J{\o}rgensen, {K A}",
note = "{\circledC} 2012 The Authors. Diabetic Medicine {\circledC} 2012 Diabetes UK.",
year = "2012",
doi = "10.1111/dme.12028",
language = "English",
volume = "29",
pages = "e440--4",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "12",

}

RIS

TY - JOUR

T1 - The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion

T2 - a randomized crossover trial in uraemic patients

AU - Øzbay, Aygen

AU - Møller, N

AU - Juhl, C

AU - Bjerre, M

AU - Carstens, J

AU - Rungby, J

AU - Jørgensen, K A

N1 - © 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.

PY - 2012

Y1 - 2012

N2 - The calcineurin inhibitors cyclosporine and tacrolimus are implicated in post-transplant complications such as new-onset diabetes after transplantation. The relative contribution of each calcineurin inhibitor to new-onset diabetes after transplantation remains unclear. We sought to compare the impact of cyclosporine and tacrolimus on glucose metabolism in humans.

AB - The calcineurin inhibitors cyclosporine and tacrolimus are implicated in post-transplant complications such as new-onset diabetes after transplantation. The relative contribution of each calcineurin inhibitor to new-onset diabetes after transplantation remains unclear. We sought to compare the impact of cyclosporine and tacrolimus on glucose metabolism in humans.

U2 - 10.1111/dme.12028

DO - 10.1111/dme.12028

M3 - Journal article

VL - 29

SP - e440-4

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 12

ER -